]>
IRCT20211023052851N1 IRCT 2021-12-19 Karaj University of Medical Sciences The effect of ketamine in improving renal colic pain Comparision of the efficacy of IV ketamine with IV morphine and IV ketorolac in patients with renal colic 2021-11-08 anticipated 126 Complete https://irct.ir/trial/59577 interventional Randomization: Not randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Blinding description: The patient will only be told that we will prescribe painkillers, but only the participant will be unaware of the medication received. 2-3 Renal colic. Intervention 1: Intervention group: Patients with renal colic pain who received intravenous ketamine. In this group of patients, 10% ketamine is slowly injected intravenously and the dosage is equivalent to 0.5 mg / kg body weight. This injection is given only once and its therapeutic effects are evaluated 6 hours after the injection. this drug is made by ROTEXMEDICA Pharmaceutical company. Intervention 2: Control group: Patients with renal colic who received intravenous morphine. Patients in this group receive 3 mg of diluted 1% morphine intravenously and slowly. This injection is given only once and the results are evaluated up to 6 hours after the injection. this drug is made by ROTEXMEDICA Pharmaceutical company. Intervention 3: Control group: Patients with renal colic pain who received intravenous ketorolac. In this group of patients, one 30 mg Ketrolac ampule, equivalent to one ml is injected intravenously. This injection is given only once and Results are evaluated 2 hours after injection. This drug is produced by Raha Pharmaceutical Company. Yes - There is a plan to make this available What will be shared: Data on pain in renal colic patients after ketamine administration after patients were not identified Data on pain in renal colic patients after morphine administration after patients were not identified Data on pain in renal colic patients after administration of ketrolac after patients are not identified When: Access to data 6 months after the publication of the article To whom: Researchers workers in medical academic institutions Conditions: Allow access to compare with other painkillers as well as scale with pain relief in other diseases Where to obtain: to this email adress: l32fereshteh@gmail.com How to obtain: The data will be reviewed and submitted within one business week upon request Comments:
public Mohamad Reza Maghsoodi
Madani hospital, Jahanshahr blvd.
Karaj Iran (Islamic Republic of) 1411953473 +98 21 8833 1084 dr.maghsoudi.m@gmail.com Karaj University of Medical Sciences scientific Mohamad Reza Maghsoodi
Madani hospital, Jahanshahr blvd.
Karaj Iran (Islamic Republic of) 1411953473 +98 21 8833 1084 dr.maghsoudi.m@gmail.com Karaj University of Medical Sciences Iran (Islamic Republic of) All patients with renal colic pain no limit no limit Both Taking opium drugs in past 6 hours History of bipolar and psychological disease N23 Unspecified renal colic Treatment - Drugs Treatment - Drugs Treatment - Drugs Intervention group: Patients with renal colic pain who received intravenous ketamine. In this group of patients, 10% ketamine is slowly injected intravenously and the dosage is equivalent to 0.5 mg / kg body weight. This injection is given only once and its therapeutic effects are evaluated 6 hours after the injection. this drug is made by ROTEXMEDICA Pharmaceutical company. Control group: Patients with renal colic who received intravenous morphine. Patients in this group receive 3 mg of diluted 1% morphine intravenously and slowly. This injection is given only once and the results are evaluated up to 6 hours after the injection. this drug is made by ROTEXMEDICA Pharmaceutical company. Control group: Patients with renal colic pain who received intravenous ketorolac. In this group of patients, one 30 mg Ketrolac ampule, equivalent to one ml is injected intravenously. This injection is given only once and Results are evaluated 2 hours after injection. This drug is produced by Raha Pharmaceutical Company. The rate of patient pain reduction. Timepoint: Will assess the severity of pain and side effects at 5, 15, 30 and 60 minutes after drug administration. Method of measurement: The patient is asked to give a score of 10 for the most severe pain he or she has ever experienced, and to rate his or her current pain accordingly. Deputy of Research of Karaj University of Medical Sciences Approved 2021-03-06 Ethics committee of Alborz University of Medical Science Office of the Ethics Committee-Second Floor-Deputy of Research and Technology-Saffarian Alley-45 meters from Golshahr Karaj Alborz Iran (Islamic Republic of)